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Abstract The cell surface hydrolase tissue non-specific alka-
line phosphatase (TNAP) (also known as MSCA-1) is used to
identify a sub-population of bone marrow stromal cells
(BMSCs) with high mineralising potential and is found on
subsets of cells within the dental pulp. We aim to determine
whether TNAP is co-expressed by human dental pulp stromal
cells (hDPSCs) alongside a range of BMSC markers, whether
this is an active form of the enzyme and the effects of culture
duration and cell density on its expression. Cells from primary
dental pulp and culture expanded hDPSCs expressed TNAP.
Subsequent analyses revealed persistent TNAP expression
and co-expression with BMSC markers such as CD73 and
CD90. Flow cytometry and biochemical assays showed that
increased culture durations and cell densities enhanced TNAP
expression by hDPSCs. Arresting the hDPSC cell cycle also
increased TNAP expression. These data confirm that TNAP is
co-expressed by hDPSCs together with other BMSC markers
and show that cell density affects TNAP expression levels. We
conclude that TNAP is a potentially useful marker for hDPSC
selection especially for uses in mineralised tissue regenerative
therapies.
Keywords Tissue non-specific alkaline phosphatase . Dental
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Introduction
The alkaline phosphatase (ALP) hydrolases are a group of
three isoenzymes responsible for the dephosphorylation of
a variety of molecules associated with a range of biological
processes (Moss 1982). Of the three ALP isoforms in
humans, two—intestinal and placental—are tissue specific.
The third, tissue non-specific ALP (TNAP), is found in
many tissues including bone, liver and kidney (Mckenna
et al. 1979). ALPs are cell surface glycoproteins but can
also be found in serum as a result of cell death and as such
they are useful diagnostic biomarkers for a range of dis-
eases including metastatic cancers and Paget’s disease of
bone (Brown et al. 2005; Cathala and Brunel 1975; Jaffe
and Bodansky 1943; Price et al. 1980). ALP is also used in
in vitro assays as a marker of differentiation, especially in
osteogenic cell cultures (Matsui et al. 1992; Sudo et al.
1983). Recent reports using human bone marrow stromal
cells (BMSCs) have described the use of TNAP as a selec-
tive marker for the isolation of BMSCs from a mixed pop-
ulation (Battula et al. 2009). These authors described TNAP
as Bmesenchymal stem cell antigen-1 (MSCA-1)^; howev-
er, further studies confirmed that TNAP and MSCA-1 are
the same antigen (Sobiesiak et al. 2010). We will therefore
refer to TNAP throughout this paper.
In dental tissues, TNAP is expressed by ameloblasts,
odontoblasts and stratum intermedium cells of the dental
pulp (Hoshi et al. 1997; Hotton et al. 1999; Lezot et al.
2006). This expression is likely to be related to the role of
these cells in enamel and dentine biomineralisation, where
availability of phosphate ions is essential for hydroxyapa-
tite nucleation and secondary crystal growth. However,
what is not known is the extent to which human dental
pulp stromal cells (hDPSCs) express TNAP. hDPSCs, first
described in 2000 by Gronthos et al. are resident in low
numbers in the dental pulp but are capable of mass
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expansion upon induction in in vitro culture (Gronthos
et al. 2000). hDPSCs are of the mesenchymal lineage, ca-
pable of plastic adherence, colony formation and in vitro
differentiation toward the dentinogenic, chondrogenic and
myogenic lineages, as well as expressing the cell surface
markers CD73, CD90 and CD105 (Dominici et al. 2006;
Gronthos et al. 2002; Zhang et al. 2006). Previously, ex-
pression of ALP by cultured hDPSCs has been determined
biochemically and used as a marker for the cells’ ability to
produce mineralised matrix in vitro (Gronthos et al. 2000;
Luisi et al. 2007; Wei et al. 2007).
Following the discovery of hDPSCs and confirmation
of their potential to form a mineralised matrix, they have
been seen as a potential source of cells for dental tissue
engineering as well as an alternative cell source for use in
reparative orthopaedic procedures (D’aquino et al. 2008;
Gronthos et al. 2002; Krebsbach and Robey 2002). This
is due to their relative ease of access for banking (e.g.,
f rom the deciduous dent i t ion) as wel l as their
mineralisation potential in vitro (El-Gendy et al. 2013;
Gronthos et al. 2000; Karaöz et al. 2010; Pivoriūnas
et al. 2009). However, low tissue volume and subsequent
low cell numbers limit hDPSC translational utility, as
ex vivo expansion is required in order to achieve clini-
cally significant cell numbers for regenerative therapies
(Bianco and Robey 2001; Guillot et al. 2007). Cell ex-
pansion can lead to potential problems, such as telomere
shortening, changes to gene expression profiles and a
reduction in mineralisation potential, which is a cause
for concern for re-implantation strategies (Mokry et al.
2010; Zhang et al. 2008). A further potential problem
with in vitro expansion of cells for transplantation is that
of possible cell heterogeneity. One way to partially over-
come this is to use cell separation technologies to isolate
populations of cells that are likely to be clinically use-
ful. For example, for dental and orthopaedic repair, it
would be potentially beneficial to isolate cells that are
predisposed to differentiate toward a mineralising phe-
notype. However, for this to be achieved, candidate cell
surface markers must first be identified, as currently
markers that can be used to predict the mineralisation
potential of hDPSCs are scarce. TNAP is one such can-
didate marker.
The aim of this work is to increase our understanding of
TNAP expression by hDPSCs. Our hypothesis was that, as
TNAP is expressed by BMSCs, then as phenotypically similar
cells, hDPSCs should also express this marker. hDPSC ex-
pression of TNAP should therefore map to the stromal cell
compartment and be maintained throughout cell culture. In
this report, we describe the expression of TNAP by cultured
hDPSCs, co-expression of TNAP with dental stromal cell
markers and modulation of expression by cell density and
proliferation potential.
Methods
Cell extraction and isolation
hDPSCs were isolated from extracted impacted third molars
obtained with patient consent through the Leeds Dental Insti-
tute Research Tissue Bank (07/H1306/93+5). Donors were
both male (5) and female (7) and 18–38 years of age (n=
12). Tooth surfaces were cleaned with 70 % (v/v) ethanol-
soaked tissue paper and any attached soft tissue was removed
with a sterile scalpel blade. Teeth were fractured to allow
exposure of the dental pulp, which was gently removed from
the tooth fragments with sterile forceps. Extracted pulps were
mechanically disrupted with a scalpel blade and digested in a
solution of 3 mg/mL collagenase type I (Sigma-Aldrich,
Poole, UK) and 4 mg/mL dispase (Roche, Mannheim, Ger-
many) for 30 min at 37 °C with gentle agitation on a
MACSmix tube rotator (Miltenyi Biotec, Bergisch Gladbach,
Germany). The resulting suspension was passed through a
70-μm filter (BD Biosciences, San Jose, CA, USA) and cen-
trifuged at 200g for 5 min before resuspension of the cell pellet
in alpha modification of Eagle’s medium (α-MEM) (Life
Technologies, Paisley, UK) supplemented with 15 % FCS
(Biosera, Ringmer, UK), 2 mM L-glutamine (Sigma-
Aldrich) and 100 units/mL penicillin/100 μg/mL streptomy-
cin (Sigma-Aldrich). Resuspended cells were incubated in
T25 flasks (Corning, Amsterdam, Netherlands) at 37 °C in
5 % CO2 in air at a ratio of 1 digested pulp per flask for 10–
14 days or taken directly for flow cytometry. Human gingival
fibroblasts (hGFs) were isolated from gingival tissue attached
to the same third molar teeth used for pulp isolations. The
tissue was removed from the tooth with forceps and subse-
quently mechanically disrupted with a scalpel blade before
tissue fragments were plated into T75 flasks and cultured in
α-MEM containing 10 % FCS, 2 mM L-glutamine and 100
units/mL penicillin/100 μg/mL streptomycin at 37 °C in 5 %
CO2 in air for 10–14 days to allow for hGFs to adhere and
proliferate.
Cell culture
Digested pulps were cultured for 10–14 days before assess-
ment of colony formation. Subconfluent flasks were passaged
by digestion with 0.25 % trypsin/0.02 % EDTA (Sigma-Al-
drich) and the resulting suspension was transferred to a sterile
T175 flask at a density of 5×103 cells/cm2; this flask was
designated as p1. Passaged cells were subsequently cultured
in basal medium of α-MEM containing 10 % FCS, 2 mM L-
glutamine and 100 units/mL penicillin/100 μg/mL streptomy-
cin at 37 °C in 5 % CO2 in air until 80 % confluency. Subse-
quent passages were performed as previously described. The
same regimen was utilised for hGFs and BMSCs (Lonza,
Slough, UK).
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Time course and density cultures
hDPSCs of p2–p4 from 5 donors were seeded to 6-well plates
and cultured in basal medium at 37 °C in 5 % CO2 in air for
varying times and at varying densities. To investigate the ef-
fect of time on TNAP expression by hDPSCs, cells were cul-
tured for 14 days at an initial seeding density of 5×103 cells/
cm2. BMSCS were similarly cultured and analysed using the
same methods. To determine the effect of cell density on
TNAP expression, hDPSCs were cultured for 1 week with
initial seeding densities ranging from 5×103–1×105 cells/
cm2 with an initial change of medium performed 24 h after
seeding to remove unattached cells. Upon termination of the
culture periods, the cells were characterised by flow cytometry
and specific staining.
Mitomycin C culture
Subconfluent p2–p4 hDPSCs from 5 donors were passaged
using 0.25 % trypsin/0.02 % EDTA, plated to T75 flasks at a
density of 5×103 cells/cm2 and cultured for 24 h to allow
cellular adhesion. After 24 h, the basal medium was supple-
mented with 20 μg/mL mitomycin C (Sigma-Aldrich) to in-
hibit cell proliferation and incubated for 2 h at 37 °C in 5 %
CO2 in air before washing with PBS and replacement with
fresh basal medium. Cells were subsequently cultured and
analysed by flow cytometry at defined time points.
Flow cytometry
Cells for flow cytometry were detached with 0.25 % trypsin/
0.02 % EDTA and the subsequent suspension was centrifuged
to leave a cell pellet. Primary cells were used immediately
post-isolation. Cells were then resuspended in magnetic acti-
vated cell sorting buffer (MACS) buffer [(consisting of PBS
containing 2 mM EDTA (Alfa Aesar, Heysham, UK) and
0.5 % BSA (Sigma-Aldrich)] and FcR blocking solution
(Miltenyi Biotec) before incubation with various antibodies
(10 μL per 1×106 cells unless stated) in a total volume of
100 μL for 20 min at room temperature in the dark. Following
labelling, 900 μL of MACS buffer was added to each sample
before centrifugation and resuspension in 500 μL of MACS
buffer. Samples were analysed using a BD LSRFortessa flow
cytometer running BD FACSDiva software and subsequent
data analysis was performed using FlowJo (Tree Star,
Ashland, OR, USA). Antibodies used were as follows:
CD29-Alexa Fluor 488 (5 μL per 1×106 cells), CD31-PE,
CD34-FITC, CD44-FITC, CD45-PE, CD56-PE, CD73-PE
(2 μL per 1×106 cells), CD90-APC, CD105-FITC, CD106-
PE, CD146-Alexa Fluor 488 (5 μL per 1×106 cells), CD166-
PE and TNAP-APC (all Biolegend, San Diego, CA, USA)
(detailed in Table 1). 7-AAD (Biolegend) was used as a via-
bility dye. All threshold values for flow cytometry were
Table 1 Cell surface markers used in co-expression analysis of
hDPSCs expressing TNAP; each marker is listed with alternative
names, a brief description of cell distribution and a brief explanation of
function
Marker Marker of Reference
CD29 / Integrin β1 Marker of some
haematopoietic cells
and stromal cells,
involved in cell-cell and
cell-matrix adhesion,
including binding to
fibronectin.
(Hynes 1992)
CD31 / Platelet
Endothelial Cell
Adhesion Molecule-1
(PECAM-1)
Marker of endothelial cells
and some
haematopoietic cells.
Involved in
angiogenesis and as a
mechanosensor.
(Newman et al.
1990)
CD34 Haematopoietic stem cell
marker, involved in
attachment to matrix
and stromal cells.
(Krause et al.
1996)
CD44 / Homing Cell
Adhesion Molecule
(H-CAM)
Adhesion molecule found
on many cell types, acts
as a hyaluronate
receptor.
(Aruffo et al.
1990)
CD45 / Leukocyte
Common Antigen
(LCA) / Protein
tyrosine phosphatase
receptor type C
(PTPRC)
Marker of many
haematopoietic cells,
involved in T and B cell
receptor-mediated
activation.
(Trowbridge and
Thomas 1994)
CD56 / Neural Cell
Adhesion Molecule
(N-CAM)
Found on neural cells,
some lymphocytes and
skeletal cells, has
functions in cell-cell
adhesion.
(Sinanan et al.
2004)
CD73 / Ecto-5’-
nucleotidase
Expressed by multiple cell
types, including some
haematopoietic cells,
stromal cells, epithelial
cells and BMSCs.
Catalyses AMP to
adenosine and has some
cell adhesion
functionality.
(Airas et al.
1997; Barry
et al. 2001)
CD90 / Thy-1 Marker of some
haematopoietic stem
cells, fibroblasts and
BMSCs. Regulates cell
adhesion and T cell
activation.
(Ghilzon et al.
1999; Rege
and Hagood
2006)
CD105 / Endoglin Marker of endothelial
cells, immune cells and
MSCs. Part of the
TGF-β receptor
complex with a key role
in angiogenesis.
(Fonsatti et al.
2003)
CD106 / Vascular Cell
Adhesion Molecule-1
(VCAM-1)
Marker of endothelial cells
and some BMSCs.
Regulates adhesion of
mononuclear cells in the
blood to vasculature.
(Carter and
Wicks 2001)
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obtained by analysing both autofluorescence of non-labelled
hDPSCs and reactivity of isotype matched controls. Events
were gated based on forward and side scatter and colour com-
pensation was performed for each panel.
ALP staining
ALP activity was assessed using the leukocyte alkaline phos-
phatase kit (Sigma-Aldrich) based on napthol AS-MX phos-
phate and Fast blue RR salt, performed as per the manufac-
turer’s instructions. Briefly, monolayer cultures from 3 donors
were fixed and subsequently incubated with 0.01 % napthol
AS-MX with Fast blue RR salt in deionised water for 30 min
in the dark.
Magnetic cell separation
Cultured hDPSCs were detached with 0.25 % trypsin/0.02 %
EDTA treatment and the subsequent suspension was centri-
fuged to leave a cell pellet. The resulting cells were resuspend-
ed in 70 μL MACS buffer, 10 μL FcR blocker and 20 μL
TNAP-APC for 15min at room temperature in the dark before
the addition of 900 μL MACS buffer. Cells were centrifuged
and resuspended in 70 μL MACS buffer, 10 μL FcR blocker
and 20 μL anti-APC microbeads (Miltenyi Biotec) before in-
cubation at 4 °C for 15 min. Labelled cells were centrifuged
and resuspended in 1 mL MACS buffer before addition to a
magnetised LS MACS column, then columns were washed
with 1 mL MACS buffer (×3). Eluted unlabelled cells were
collected and designated the TNAP− (negative) fraction. La-
belled cells, retained on the column, were isolated by
demagnetising the column and washing with 2 mL of MACS
buffer and were designated the TNAP+ (positive) fraction.
CFU-f assays
TNAP sorted hDPSCs were counted using a Scepter 2.0 cell
counter (Millipore, Billerica, MA, USA), diluted and seeded
to 6-well plates at a concentration of 500 cells per well. Cells
were cultured for 9 days at 37 °C in 5 % CO2 in air before
fixation with 10 % (v/v) neutral buffered formalin (Sigma-
Aldrich) and staining with 1 % (w/v) methyl violet (VWR,
UK) for 30 min before washing and colony counting.
Trilineage differentiation
hDPSCs sorted to be either TNAP+ or TNAP- were seeded to
either 6-well plates at a density of 2.5×104 cells/cm2 for oste-
ogenic and adipogenic differentiation or to centrifuge tubes at
a final count of 2×105 total cells for chondrogenic
differentiation.
Osteogenic differentiation
Plated hDPSCs were cultured for 24 h to allow for adherence
and spreading before media was aspirated and non-adherent
cells were removed. Cells were then cultured in StemPro Oste-
ogenic Differentiationmedia (Life Technologies) for 2weeks at
37 °C in 5 % CO2 in air with media changes every 3 days.
Then, the culture cells were fixed in 70 % ethanol for 1 h,
washed 3 times with dH2O and stained with 2 % (w/v) Alizarin
Red in dH2O (Sigma-Aldrich) pH 4.2 for 10 min. Samples
were then washed 5 times with dH2O before imaging.
Adipogenic differentiation
Plated hDPSCs were cultured for 24 h to allow for adherence
and spreading before media was aspirated and non-adherent
cells were removed. Cells were then cultured in StemPro
Adipogenic Differentiation media (Life Technologies) for
2 weeks at 37 °C in 5 % CO2 in air with media changes every
3 days. Then, the culture cells were washed twice in PBS and
fixed in 10 % formalin for 10 min before further fixation in
fresh 10 % formalin for 1 h. Fixed cells were washed twice
with dH2O and once with 60 % (v/v) isopropanol in dH2O for
5 min before air drying at RT. Cells were stained with Oil Red
O working solution [Oil Red O stock solution (0.35 g Oil Red
O in 100 mL isopropanol) diluted 3:2 with dH2O, passed
through a 0.2-μm filter] for 10 min before being washed 4
times in dH2O and imaged.
Chondrogenic differentiation
Sorted hDPSCs in centrifuge tubes were pelleted by centrifu-
gation at 400g for 10 minutes and incubated for 1 h in basal
media. Following this incubation, the media was aspirated and
replaced with StemPro Chondrogenic Differentiation media
Table 1 (continued)
Marker Marker of Reference
CD146 / Melanoma Cell
Adhesion Molecule
(MCAM)
Cell adhesion molecule
involved in heterophilic
cell-cell interactions.
Found on many cell
types including
endothelium, epithelial
cells and MSCs.
(Crisan et al.
2008; Shih
1999)
CD166 / Activated
Leukocyte Cell
Adhesion Molecule
(LCAM)
Found on T cells,
monocytes, epithelial
cells and BMSCs.
Mediates T cell
development in the
thymus and potentially
osteogenic
differentiation.
(Bowen et al.
1997; Bruder
et al. 1998)
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(Life Technologies), cells were cultured for 2 weeks at 37 °C
in 5 % CO2 in air with media changes every 3 days. Then, the
culture cells were washed twice in PBS and fixed in 10 %
formalin for 10 min before further fixation in fresh 10 % for-
malin for 1 h. Fixed cells were washed twice with dH2O and
once with 3 % (v/v) acetic acid in dH2O for 3 min before
staining with 1 % (w/v) Alcian Blue in 3 % (v/v) acetic acid
for 30 min. Samples were then washed 3 times in dH2O and
imaged.
Immunofluorescence staining
High (5×104 cells/cm2) and low (5×103 cells/cm2) density
cell cultures were cultured for 4 days in basal media at
37 °C in 5 % CO2 in air before fixation in 70 % (v/v) ethanol
for 15 min Fixed samples were permeabilised by incubation
with 0.1 % Triton X-100 in PBS for 15 min before washing in
PBS and blocking with pre-diluted goat serum (GeneTex, Ir-
vine, CA, USA) for 30 min at 37 °C. Samples were then
incubated with primary antibodies at dilutions between 1:50
and 1:250 overnight at 4 °C. Primary antibodies used were
anti-cytokeratin 19 (FITC conjugated) (Santa Cruz Biotech-
nology, Dallas, TX, USA), anti-vimentin, anti-nestin and anti-
fibronectin (all Abcam, Cambridge, UK). Non-conjugated pri-
mary antibodies were labelled with anti-rabbit IgG Alexa Flu-
or 488 (Abcam) for 30 min in the dark. Samples were then
stained with DAPI for 15 min at room temperature to visualise
nuclei before washing in PBS. Samples were then imaged
using a Zeiss Axio Vert.A1 running Zen 2012 software (Carl
Zeiss, Oberkochen, Germany).
Statistical analysis
All measurements were performed in at least triplicate and all
graphs are displayed as the mean±SEM. The data were sub-
sequently analysed for Gaussian distribution using the
Shaprio–Wilk test, normally distributed data between two sep-
arate samples were analysed using a two-sample t test and
non-parametric data were tested using the Mann–Whitney U
test. Paired parametric data were tested using a paired t test.
Statistical analysis was performed in IBMSPSS Statistics v.22
(IBM, Armonk, NY, USA) and P values of less than 0.05
were considered significant, 0.01 very significant and 0.001
extremely significant.
Results
TNAP is expressed by a sub-set of primary dental pulp cells
Analysis of whole digested dental pulp by flow cytometry
confirmed the presence of TNAP+ cells within the primary
dental pulp (Fig. 1a). TNAP+ cells were present at ratios be-
tween 2 and 10 % of total cells and these values show consis-
tency with the expected number of odontoblasts in primary
dental pulp (Murray et al. 2002; Vavpotič et al. 2009). Cell
sorting of dental pulp with TNAP did not give proliferative,
colony-forming cells (data not shown). Analysis by flow cy-
tometry of adherent p0 hDPSCs, derived from pulp digestion
and subsequent colony formation without sorting, showed a
subset of cells expressing TNAP, co-expressed with the
BMSC marker CD105 (Fig. 1b). This expression was ob-
served on cells derived from 5 donors and was consistently
found on between 2 and 8 % of total adherent hDPSCs. Sub-
sequent flow cytometric analysis of cultured hDPSCs over
multiple passages, up to p7, showed that TNAP expression
was sustained throughout expansion culture (Fig. 2). Expres-
sion was found to vary between 1 and 5 % of total cells, with
no apparent differences found between expression levels over
passage.
TNAP is co-expressed with multiple markers of hDPSCs
Following confirmation of the persistence of TNAP expres-
sion, multiple markers of hDPSCs (see Table 1) were analysed
to determine their co-expression with TNAP. hDPSC popula-
tions were found to be uniformly positive for CD29, CD44,
CD73, CD90 and CD166, express CD56 and CD146 to vary-
ing degrees and be negative for CD31 and CD45 (Fig. 3).
Expression of each marker was found to be independent of
TNAP expression, with no difference seen in the expression
profile of each marker for TNAP+ or TNAP- hDPSCs.
Expression of TNAP by hDPSCs is increased by extended
periods in culture
All the above analyses of hDPSCs investigating initial TNAP
expression levels and co-expression were performed on sub-
confluent (80–90 % confluency) cell monolayers or initial
Fig. 1 Representative FACS plots showing flow cytometric analysis of
TNAP expression by a digested human dental pulp with 7-AAD viability
dye co-staining and b p0 culture expanded adherent hDPSCs with CD105
co-expression. These data confirm TNAP expression in both primary
dental pulp and p0 culture expanded adherent hDPSCs
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colonies. However, when hDPSCs were seeded at defined
concentrations and cultured for up to 2 weeks without
passage, it was found that TNAP expression levels increased
with time (Fig. 4). Expression levels were found to be less
Fig. 2 Representative FACS
plots showing TNAP/CD73 co-
expression across passages from
p2 to p7 (a–f). TNAP was found
to be stably expressed throughout
culture and over multiple
passages it was expressed bywhat
appeared to be a consistent
percentage of hDPSCs
Fig. 3 Representative FACS
plots showing TNAP co-
expression with the common
dental stromal cell markers CD29
(a), CD44 (b), CD56 (c), CD73
(d), CD90 (e), CD146 (f) and
CD166 (g) and the negative
control markers CD31 (h) and
CD45 (i). These data show that
TNAP is co-expressed with other
common markers of hDPSCs and
does not map to a separate
subpopulation of hDPSCs
Cell Tissue Res
than 1 % at day 4, steadily rising over time to 26 % of
cells by day 14. These findings were in contrast to BMSC
controls that had almost uniform expression of TNAP at all
timepoints.
Expression of TNAP by hDPSCs is increased at high cell
density
Following these findings, we wished to determine whether the
observed increase in TNAP+ hDPSCs over timewas related to
cell density as opposed to time in culture. The effect on TNAP
expression of varying hDPSC seeding density was therefore
assessed. In these experiments, hGFs were used as a control
with low TNAP expression (Somerman et al. 1988). hDPSCs
and hGFs were seeded between 5×103 cells/cm2 and 1×105
cells/cm2 and cultured for 7 days. TNAP expression was then
determined by flow cytometry. At low seeding densities (5×
103 cells/cm2), 5.08 % of hDPSCs were found to express
TNAP after 7 days (Fig. 5a) compared to 34.26 % at high
seeding densities (1×105 cells/cm2) (p=0.03). Seeding densi-
ties between these values showed a gradual increase in TNAP
expression. In comparison, hGFs were found to express
TNAP at levels of 0.43 and 7.3 % at comparative seeding
densities with a gradual increase of expression observed be-
tween these values. Therefore, it can be seen that there is a
significant difference between the expression of TNAP on
hDPSCs and hGFs at both low (p=0.021) and high (p=
0.03) seeding densities. The activity of hDPSC TNAP was
confirmed by cytological staining, which showed increased
ALP-positive staining with increasing cell density (Fig. 5b).
Assessment of cytoskeletal proteins
Immunofluorescence staining for the cytoskeletal elements
vimentin, nestin, fibronectin and cytokeratin 19 in hDPSCs
cultured for 4 days at low density (5×103 cells/cm2) and high
density (5×104 cells/cm2) showed that these cells are positive
for vimentin, nestin and fibronectin. Vimentin staining was
uniformly positive at both high and low densities while fibro-
nectin production increased with increasing cell density
(Fig. 6a, c, d, f). Nestin was present at low cell densities;
however, when density increased nestin production was re-
duced (Fig. 6b, e), cells were negative for cytokeratin 19 at
both high and low densities (data not shown).
Sorting of hDPSCs for TNAP expression
To test whether TNAP+ hDPSCs represent a separate cell
population, we employed magnetic cell separation to isolate
both TNAP+ (positive) and TNAP− (negative) populations
from cultured hDPSCs. These cells were then assessed for
colony-forming capacity and differentiation potential. CFU-f
assays showed that there was no significant difference in the
number of colonies formed by either cell type (p=0.58) al-
though there were on average more colonies present in the
Fig. 4 Representative FACS
plots showing TNAP expression
by hDPSCs (a–d) and BMSCs
(e–h) over a 14-day time course
(a, e Day 4, b, f Day 7, c, g Day
11, d, h Day 14). All cells were
seeded at an initial density of 5×
103 cells/cm2. These data show
increasing expression of TNAP
over time by both hDPSCs and
BMSCs
Fig. 5 Production of TNAP with increasing cell density. a Flow
cytometric analysis of TNAP expression by hDPSCs and hGFs with
increasing cell density showing the percentage of cells to express
TNAP. b Cytological staining of TNAP in cell cultures seeded with
increasing density using napthol AS-MX and Fast blue RR salt. These
data show that TNAP expression increases with increasing cell density.
n=5. *p≤0.05, **p≤0.01
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TNAP+ fraction (Fig. 7a). Trilineage differentiation experi-
ments showed that both cell populations were capable of
in vitro mineralisation, producing strongly Alizarin Red
stained mineral deposits across the culture dish, although the
deposits in the TNAP+ cells were slightly more uniform
across the culture vessel (Fig. 7b, c). The cells from both
populations were also capable of producing glycosaminogly-
cans (GAGs) in in vitro pellet cultures, as shown by Alcian
Blue staining (Fig. 7d, e). Neither cell type was able to pro-
duce lipid droplets in vitro as determined by Oil Red O stain-
ing (data not shown).
Expression of TNAP by hDPSCs is increased by inhibition
of hDPSC proliferation
Given that cell proliferation would be expected to be
inhibited at the higher cell density values tested, we decid-
ed to mimic this effect with mitomycin C treatment in
comparatively low density cultures. Following treatment,
we measured TNAP expression by mitotically arrested
hDPSCs to determine the effect of inhibition of prolifera-
tion at several time points and seeding densities. Flow cy-
tometric analysis of TNAP expression by mitomycin C-
treated cells revealed that 1.2 % of hDPSCs, seeded at
2×104 cells/cm2, expressed TNAP 1 day post-treatment
and this proportion then rose significantly to 12.8 % after
4 days, (p=0.003) (Fig. 8a). A further rise in TNAP ex-
pression from 12.8 to 17.7 % was observed between Days
4 and 14. Assessment of varying seeding densities follow-
ing mitomycin C treatment showed no difference in TNAP
activity after 1 week in culture (p values between 0.421
and 0.835) (Fig. 8b).
Discussion
This study demonstrated that TNAP is present in human
dental pulp in vivo and on cultured hDPSCs in vitro; these
findings are complementary to previous studies that have
shown the expression of TNAP by odontoblasts in vivo and
BMSCs in vitro (Battula et al. 2009; Hotton et al. 1999). We
also showed that TNAP production in vitro is affected by the
density and proliferative ability of the cells in culture and that
cytoskeletal markers are also affected by density.
Uncultured, digested human dental pulp found TNAP to be
expressed by approximately 2–10 % of cells, which shows
consistency with previous findings on odontoblast cell density
(Murray et al. 2002; Vavpotič et al. 2009). Cell sorting exper-
iments for TNAP using primary dental pulp did not yield
proliferative, adherent cells (data not shown); it is therefore
probable that the TNAP positive cells identified in the
digested human pulp were not from a stromal cell type. Anal-
ysis of colony-derived adherent hDPSCs confirmed the pres-
ence of TNAP on a small population of proliferative, adherent
cells. However, these were unlikely to contain cells derived
from primary odontoblasts due to the difficulty in culturing
these cells in vitro (Holt et al. 2001). Taken together, the find-
ings of TNAP presentation by both primary dental pulp and
dental pulp-derived adherent cells shows that, whilst TNAP is
present on specialised cells in vivo, it appears that it subse-
quently becomes expressed by more proliferative (and pre-
sumably less specialised) cells in vitro.
To confirm that TNAP was expressed by proliferative
hDPSCs flow cytometric studies were performed. These stud-
ies showed that TNAP was expressed consistently throughout
culture from passage 2 to 7 with no apparent differences
Fig . 6 Effec t o f ce l l dens i ty on cy toske le ta l p ro te ins .
Immunofluorescence staining (Alexa Fluor 488 secondary antibody)
with DAPI nuclear staining showing a fibronectin, b nestin and c
vimentin staining of high density (seeded at 5×104 cells/cm2) hDPSCs.
Low density (seeded at 5×103 cells/cm2) hDPSCs were also stained with
d fibronectin, e nestin and f vimentin. Fibronectin appears to be
upregulated as hDPSCs increase in density whereas nestin production is
reduced. Vimentin production is unaffected by cell density. Scale bar
100 μm
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between expression levels observed. That the expression level
of TNAP is static over multiple passages confirms that TNAP
is present on proliferating cells, as this proportion would de-
crease if TNAP+ cells were static.
Following confirmation of the persistence of TNAP ex-
pression in cultured hDPSCs, the question of whether TNAP+
cells constituted a separate subpopulation of hDPSCs was
examined by investigating TNAP co-expression with multiple
known hDPSC markers. The results from these experiments
showed that TNAP expression was grouped with the expres-
sion of all common hDPSC markers tested; no divergent
populations were observed. TNAP is therefore apparently
not associated with a unique subpopulation of hDPSCs, or a
contaminating cell type and hDPSCs retain their phenotype
whilst expressing TNAP. This finding is interesting because it
shows that TNAP expression is resident within the hDPSC
population, suggesting that a small number of these cells are
undergoing phenotypic changes. Further studies with hDPSCs
in culture for extended periods showed that over a 14-day
period there was a steady increase in TNAP expression with
over 26 % of hDPSCs ultimately expressing TNAP. This in-
crease occurred in basal medium in the absence of
Fig. 7 Sorting of hDPSCs for
TNAP. a Graph showing CFU-f
formation by TNAP+ and TNAP-
hDPSCs, no significant difference
was observed, n=20. b Alizarin
red staining of osteogenically
differentiated TNAP+ hDPSCs; c
TNAP− cells showing capacity of
hDPSCs to mineralize. d Alcian
blue staining of a
chondrogenically differentiated
TNAP+ hDPSC pellet; e a
TNAP– pellet showing GAG
production by pelleted hDPSCs.
Scale bar 100 μm for alizarin red-
stained samples, 250 μm for
alcian blue-stained pellets
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osteoinductive cues. This is potentially an important point, as
TNAP expression is often taken as being evidence of induced
osteogenic differentiation (Cheng et al. 1994; Ikeda et al.
2006; Jaiswal et al. 2000). Experiments using osteogenic cul-
tures often measure ALP expression over a period of 21–35
days and potentially there could be an intrinsic increase in
TNAP expression over time in culture (Wei et al. 2007;Woods
et al. 2009). If hDPSC expression of TNAP is intrinsic to
some cells within the population, then this potentially has
implications for studies utilising ALP as a marker or other
outcome measure following intervention, as in this instance
TNAP was present in the absence of osteoinductive cues. It is
also possible that osteogenic differentiation is a default path-
way for hDPSCs in in vitro culture and that these cells are
already in the early stages of differentiation. What both these
points highlight is the need to better understand the mecha-
nism of TNAP upregulation in hDPSCs.
TNAP expression seemed to increase more rapidly when
the hDPSCs reached confluence, suggesting that TNAP
expression might be linked to cell density. We therefore tested
the effect of increasing cell density on TNAP expression over
a fixed 7-day culture period. Increasing the initial seeding
density of hDPSCs in culture caused a significant upregula-
tion in TNAP expression over the time course with a seven-
fold increase in TNAP+ expression seen at the highest seeding
density. To test whether this was a general pattern of behaviour
amongst cells derived from the oral cavity, or a more specific
property of hDPSCs, TNAP expression was determined for
concurrent cultures of hDPSCs and hGFs at varying seeding
densities. These experiments showed that TNAP expression
by hGFs follows a similar pattern to hDPSCs with increasing
expression observed with increasing cell density. However,
the level of TNAP expression by hGFs was significantly low-
er at all seeding densities, indicating that hDPSCs are more
predisposed to increasing TNAP production and therefore po-
tentially more likely to differentiate towards a mineralised
phenotype. This apparent predisposition makes TNAP a po-
tentially interesting target for cell sorting in vitro-cultivated
hDPSCs for bone tissue engineering applications. In addition,
the density-dependent nature of TNAP expression means that
this system can potentially be controlled so as to increase
expression rapidly. Cell sorting for TNAP expression yielded
cells in both fractions that were capable of in vitro
mineralisation and GAG production. Neither positive nor neg-
ative cells were able to produce lipid droplets under
adipogenic conditions and CFU-f assays showed that colo-
nies were formed by both positive and negative cells. What
will be of interest for future work will be to determine the
sorting criteria necessary to effectively isolate the pro-
mineralising cells from dental pulp, as under the regime used
in this study there was a higher than expected degree of cell
death post-sorting, possibly related to shear sensitivity of the
sorted cells and time out of culture. Also, the in vitro
mineralisation experiments required a degree of cell expan-
sion to generate a monolayer of cells, which potentially
allowed the TNAP− cells time to upregulate TNAP produc-
tion as the cells became more dense, meaning they had be-
come phenotypically similar to the TNAP+ cells; however,
further work will be needed to elucidate this.
Interestingly, cytoskeletal elements were also seen to
change in high and low density cultures, with fibronectin
production increasing with density, whereas nestin produc-
tion reduced to barely detectable levels. These data show
that large phenotypic changes are affecting the hDPSCs as
they become dense in culture. Lineage commitment has
been previously shown to be regulated by cell shape and
cytoskeletal proteins and our data show that cytoskeletal
protein composition in hDPSCs changes as the cells begin
to become more dense in culture (Mcbeath et al. 2004).
These data indicate that cytoskeletal markers could poten-
tially be used to determine hDPSC lineage status as well as
cell surface markers such as TNAP.
Fig. 8 Flow cytometric analysis of TNAP expression by mitotically
inactivated hDPSCs seeded at 2×104 cells/cm2 and cultured for 14 days
(a) and hDPSCs seeded at varying concentrations and cultured for 7 days
(b). TNAP expression increased significantly between Days 1 and 4
cultures (p=0.003) and then steadily between Days 4 and 14. No
significant differences in TNAP expression were observed when
seeding density was varied (p=between 0.421 and 0.835). n=6, **p≤
0.01
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hDPSCs upregulate TNAP production when they are
at high cell density in vitro. To separate out the effects
of cell proliferation on our data, hDPSCs seeded at a
medium cell density were treated with mitomycin C to
arrest proliferation. The results showed that TNAP ex-
pression was significantly increased when mitosis in
hDPSCs was blocked and the cells were unable to pro-
liferate. This is potentially analogous to the scenario
whereby high density hDPSCs are unable to proliferate
due to contact inhibition, although the level of expres-
sion is lower, indicating that cell–cell contacts also play
an important role in TNAP upregulation. These results
indicate that hDPSCs begin to express TNAP when they
cannot undergo mitosis and switch from a proliferative
state to a differentiating one, making this switch inde-
pendent of external osteoinductive cues. Indeed, termi-
nal differentiation is often preceded by exit from the
cell cycle and a switch from a proliferative phenotype
to a differentiating one (Buttitta and Edgar 2007). Stud-
ies involving embryonic stem cells have also shown
that, in high density cultures, cells will switch from a
proliferative state to a differentiating one due to cell–
cell contact formation (Reubinoff et al. 2000). Further
studies with embryonic stem cells have shown that early
markers of osteogenesis, such as osterix, are upregulated
at high cell densities, indicating that contact inhibition
acts as a cue for the initiation of osteogenic differenti-
ation (Kärner et al. 2009). This is reinforced by high
density pellet and monolayer cultures of primary osteo-
blasts, which have been shown to have enhanced oste-
ogenic gene expression compared to low density mono-
layer cultures (Jahn et al. 2010).
Overall, this work has confirmed the expression of
TNAP (MSCA-1) for hDPSCs but has gone on to show
TNAP expression is persistent throughout long-term cul-
ture and maps to the proliferating compartment of iso-
lated dental pulp. We have also shown, for the first
time, that TNAP expression can be modulated by cul-
turing the cells at varying densities and that increased
TNAP expression is likely due to inhibition of prolifer-
ation, suggesting that these cells are beginning to under-
go lineage commitment in the absence of external envi-
ronmental cues. TNAP can therefore be seen as a po-
tentially useful marker for regenerative therapies involv-
ing hDPSCs.
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